302 related articles for article (PubMed ID: 22938092)
1. Redox dysregulation in the pathophysiology of schizophrenia and bipolar disorder: insights from animal models.
Kulak A; Steullet P; Cabungcal JH; Werge T; Ingason A; Cuenod M; Do KQ
Antioxid Redox Signal; 2013 Apr; 18(12):1428-43. PubMed ID: 22938092
[TBL] [Abstract][Full Text] [Related]
2. Behavioral phenotyping of glutathione-deficient mice: relevance to schizophrenia and bipolar disorder.
Kulak A; Cuenod M; Do KQ
Behav Brain Res; 2012 Jan; 226(2):563-70. PubMed ID: 22033334
[TBL] [Abstract][Full Text] [Related]
3. N-acetylcysteine normalizes neurochemical changes in the glutathione-deficient schizophrenia mouse model during development.
das Neves Duarte JM; Kulak A; Gholam-Razaee MM; Cuenod M; Gruetter R; Do KQ
Biol Psychiatry; 2012 Jun; 71(11):1006-14. PubMed ID: 21945305
[TBL] [Abstract][Full Text] [Related]
4. Early-life insults impair parvalbumin interneurons via oxidative stress: reversal by N-acetylcysteine.
Cabungcal JH; Steullet P; Kraftsik R; Cuenod M; Do KQ
Biol Psychiatry; 2013 Mar; 73(6):574-82. PubMed ID: 23140664
[TBL] [Abstract][Full Text] [Related]
5. Reduced antioxidant defense systems in schizophrenia and bipolar I disorder.
Raffa M; Barhoumi S; Atig F; Fendri C; Kerkeni A; Mechri A
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Dec; 39(2):371-5. PubMed ID: 22841966
[TBL] [Abstract][Full Text] [Related]
6. Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders.
Gawryluk JW; Wang JF; Andreazza AC; Shao L; Young LT
Int J Neuropsychopharmacol; 2011 Feb; 14(1):123-30. PubMed ID: 20633320
[TBL] [Abstract][Full Text] [Related]
7. Glutathione Deficit Affects the Integrity and Function of the Fimbria/Fornix and Anterior Commissure in Mice: Relevance for Schizophrenia.
Corcoba A; Steullet P; Duarte JM; Van de Looij Y; Monin A; Cuenod M; Gruetter R; Do KQ
Int J Neuropsychopharmacol; 2015 Oct; 19(3):pyv110. PubMed ID: 26433393
[TBL] [Abstract][Full Text] [Related]
8. Synaptic plasticity impairment and hypofunction of NMDA receptors induced by glutathione deficit: relevance to schizophrenia.
Steullet P; Neijt HC; Cuénod M; Do KQ
Neuroscience; 2006 Feb; 137(3):807-19. PubMed ID: 16330153
[TBL] [Abstract][Full Text] [Related]
9. Redox dysregulation, neurodevelopment, and schizophrenia.
Do KQ; Cabungcal JH; Frank A; Steullet P; Cuenod M
Curr Opin Neurobiol; 2009 Apr; 19(2):220-30. PubMed ID: 19481443
[TBL] [Abstract][Full Text] [Related]
10. The thalamic reticular nucleus in schizophrenia and bipolar disorder: role of parvalbumin-expressing neuron networks and oxidative stress.
Steullet P; Cabungcal JH; Bukhari SA; Ardelt MI; Pantazopoulos H; Hamati F; Salt TE; Cuenod M; Do KQ; Berretta S
Mol Psychiatry; 2018 Oct; 23(10):2057-2065. PubMed ID: 29180672
[TBL] [Abstract][Full Text] [Related]
11. Genetic dysregulation of glutathione synthesis predicts alteration of plasma thiol redox status in schizophrenia.
Gysin R; Kraftsik R; Boulat O; Bovet P; Conus P; Comte-Krieger E; Polari A; Steullet P; Preisig M; Teichmann T; Cuénod M; Do KQ
Antioxid Redox Signal; 2011 Oct; 15(7):2003-10. PubMed ID: 20673128
[TBL] [Abstract][Full Text] [Related]
12. Genetic association studies of glutamate, GABA and related genes in schizophrenia and bipolar disorder: a decade of advance.
Cherlyn SY; Woon PS; Liu JJ; Ong WY; Tsai GC; Sim K
Neurosci Biobehav Rev; 2010 May; 34(6):958-77. PubMed ID: 20060416
[TBL] [Abstract][Full Text] [Related]
13. A role for glutathione in the pathophysiology of bipolar disorder and schizophrenia? Animal models and relevance to clinical practice.
Dean OM; van den Buuse M; Bush AI; Copolov DL; Ng F; Dodd S; Berk M
Curr Med Chem; 2009; 16(23):2965-76. PubMed ID: 19689277
[TBL] [Abstract][Full Text] [Related]
14. Glutathione redox imbalance in brain disorders.
Gu F; Chauhan V; Chauhan A
Curr Opin Clin Nutr Metab Care; 2015 Jan; 18(1):89-95. PubMed ID: 25405315
[TBL] [Abstract][Full Text] [Related]
15. Redox dysregulation, neuroinflammation, and NMDA receptor hypofunction: A "central hub" in schizophrenia pathophysiology?
Steullet P; Cabungcal JH; Monin A; Dwir D; O'Donnell P; Cuenod M; Do KQ
Schizophr Res; 2016 Sep; 176(1):41-51. PubMed ID: 25000913
[TBL] [Abstract][Full Text] [Related]
16. Decreased glutathione levels and altered antioxidant defense in an animal model of schizophrenia: long-term effects of perinatal phencyclidine administration.
Radonjić NV; Knezević ID; Vilimanovich U; Kravić-Stevović T; Marina LV; Nikolić T; Todorović V; Bumbasirević V; Petronijević ND
Neuropharmacology; 2010; 58(4-5):739-45. PubMed ID: 20036264
[TBL] [Abstract][Full Text] [Related]
17. Reduction of plasma glutathione in psychosis associated with schizophrenia and bipolar disorder in translational psychiatry.
Nucifora LG; Tanaka T; Hayes LN; Kim M; Lee BJ; Matsuda T; Nucifora FC; Sedlak T; Mojtabai R; Eaton W; Sawa A
Transl Psychiatry; 2017 Aug; 7(8):e1215. PubMed ID: 28892069
[TBL] [Abstract][Full Text] [Related]
18. Monoaminergic dysregulation in glutathione-deficient mice: possible relevance to schizophrenia?
Jacobsen JP; Rodriguiz RM; Mørk A; Wetsel WC
Neuroscience; 2005; 132(4):1055-72. PubMed ID: 15857710
[TBL] [Abstract][Full Text] [Related]
19. Risperidone reverses phencyclidine induced decrease in glutathione levels and alterations of antioxidant defense in rat brain.
Stojković T; Radonjić NV; Velimirović M; Jevtić G; Popović V; Doknić M; Petronijević ND
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Oct; 39(1):192-9. PubMed ID: 22735395
[TBL] [Abstract][Full Text] [Related]
20. Glutathione deficit during development induces anomalies in the rat anterior cingulate GABAergic neurons: Relevance to schizophrenia.
Cabungcal JH; Nicolas D; Kraftsik R; Cuénod M; Do KQ; Hornung JP
Neurobiol Dis; 2006 Jun; 22(3):624-37. PubMed ID: 16481179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
